|
Esteve-Pastor MA, Rivera-Caravaca JM, Roldán-Rabadán I, Roldán V, Muñiz J, Raña-Míguez P, Ruiz-Ortiz M, Cequier Á, Bertomeu-Martínez V, Badimón L, Anguita M, Lip GYH, Marín F; FANTASIIA Investigators. Quality of oral anticoagulation with vitamin K antagonists in 'real-world' patients with atrial fibrillation: a report from the prospective multicentre FANTASIIA registry. Europace. 2018 Sep 1;20(9):1435-1441. doi: 10.1093/europace/eux314. PubMed PMID: 29095971.
AÑO: 2018; IF: 6.1
|
|
Rivera-Caravaca JM, Roldán V, Esteve-Pastor MA, Valdés M, Vicente V, Marín F, Lip GYH. Reduced Time in Therapeutic Range and Higher Mortality in Atrial Fibrillation Patients Taking Acenocoumarol. Clin Ther. 2018 Jan;40(1):114-122. doi: 10.1016/j.clinthera.2017.11.014. Epub 2017 Dec 21. PubMed PMID: 29275065.
AÑO: 2018; IF: 2.935
|
|
Rivera-Caravaca JM, Ruiz-Nodar JM, Tello-Montoliu A, Esteve-Pastor MA, Quintana-Giner M, Véliz-Martínez A, Orenes-Piñero E, Romero-Aniorte AI, Vicente-Ibarra N, Pernias-Escrig V, Carrillo-Alemán L, Candela-Sánchez E, Hortelano I, Villamía B, Sandín-Rollán M, Nuñez-Martínez L, Valdés M, Marín F. Disparities in the Estimation of Glomerular Filtration Rate According to Cockcroft-Gault, Modification of Diet in Renal Disease-4, and Chronic Kidney Disease Epidemiology Collaboration Equations and Relation With Outcomes in Patients With Acute Coronary Syndrome. J Am Heart Assoc. 2018 Apr 21;7(9). pii: e008725. doi: 10.1161/JAHA.118.008725. PubMed PMID: 29680822; PubMed Central PMCID: PMC6015275.
AÑO: 2018; IF: 4.66
|
|
Pastori D, Rivera-Caravaca JM, Esteve-Pastor MA, Roldán V, Marín F, Pignatelli P, Violi F, Lip GYH. Comparison of the 2MACE and TIMI-AF Scores for Composite Clinical Outcomes in Anticoagulated Atrial Fibrillation Patients. Circ J. 2018 Apr 25;82(5):1286-1292. doi: 10.1253/circj.CJ-17-1318. Epub 2018 Mar 16. PubMed PMID: 29553090.
AÑO: 2018; IF: 3.025
|
|
Esteve-Pastor MA, Rivera-Caravaca JM, Roldán V, Orenes-Piñero E, Romiti GF, Romanazzi I, Bai Y, Carmo J, Proietti M, Marín F, Lip GYH. Estimated Effectiveness and Safety of Nonvitamin K Antagonist Oral Anticoagulants Compared With Optimally Acenocoumarol Anticoagulated "Real-World" in Patients With Atrial Fibrillation. Am J Cardiol. 2018 Sep 1;122(5):785-792. doi: 10.1016/j.amjcard.2018.05.012. Epub 2018 Jun 2. PubMed PMID: 30049460.
AÑO: 2018; IF: 2.843
|
29095971